Cargando…

Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine

Detalles Bibliográficos
Autores principales: Berrong, Zuzana, Ahmad, Shamim, Abu Eid, Rasha, El Andaloussi, Abdeljabar, Sen, Tanusree, Stewart, Ross, Hammond, Scott A, Shrimali, Rajeev, Mkrtichyan, Mikayel, Khleif, Samir N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292459/
http://dx.doi.org/10.1186/2051-1426-2-S3-P226
_version_ 1782352489730801664
author Berrong, Zuzana
Ahmad, Shamim
Abu Eid, Rasha
El Andaloussi, Abdeljabar
Sen, Tanusree
Stewart, Ross
Hammond, Scott A
Shrimali, Rajeev
Mkrtichyan, Mikayel
Khleif, Samir N
author_facet Berrong, Zuzana
Ahmad, Shamim
Abu Eid, Rasha
El Andaloussi, Abdeljabar
Sen, Tanusree
Stewart, Ross
Hammond, Scott A
Shrimali, Rajeev
Mkrtichyan, Mikayel
Khleif, Samir N
author_sort Berrong, Zuzana
collection PubMed
description
format Online
Article
Text
id pubmed-4292459
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42924592015-01-15 Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine Berrong, Zuzana Ahmad, Shamim Abu Eid, Rasha El Andaloussi, Abdeljabar Sen, Tanusree Stewart, Ross Hammond, Scott A Shrimali, Rajeev Mkrtichyan, Mikayel Khleif, Samir N J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292459/ http://dx.doi.org/10.1186/2051-1426-2-S3-P226 Text en Copyright © 2014 Berrong et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Berrong, Zuzana
Ahmad, Shamim
Abu Eid, Rasha
El Andaloussi, Abdeljabar
Sen, Tanusree
Stewart, Ross
Hammond, Scott A
Shrimali, Rajeev
Mkrtichyan, Mikayel
Khleif, Samir N
Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
title Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
title_full Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
title_fullStr Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
title_full_unstemmed Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
title_short Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
title_sort immune combinational therapy targeting ox40 and ido synergistically enhances efficacy of a cancer vaccine
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292459/
http://dx.doi.org/10.1186/2051-1426-2-S3-P226
work_keys_str_mv AT berrongzuzana immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT ahmadshamim immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT abueidrasha immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT elandaloussiabdeljabar immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT sentanusree immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT stewartross immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT hammondscotta immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT shrimalirajeev immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT mkrtichyanmikayel immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine
AT khleifsamirn immunecombinationaltherapytargetingox40andidosynergisticallyenhancesefficacyofacancervaccine